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Abstract
Background: Streptomycin (SM) is a broad spectrum antibiotic and is an important component of any anti-
tuberculosis therapy regimen. Several mechanisms have been proposed to explain the emergence of resistance but
still our knowledge is inadequate. Proteins form a very complex network and drugs are countered by their
modification/efflux or over expression/modification of targets. As proteins manifest most of the biological
processes, these are attractive targets for developing drugs, immunodiagnostics or therapeutics. The aim of present
study was to analyze and compare the protein profile of whole cell extracts from Mycobacterium tuberculosis
clinical isolates susceptible and resistant to SM.
Results: Two-dimensional gel electrophoresis (2DE) and matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF) mass spectrometry was employed for analyzing the protein profiles. Homology and in silico
characterization for identified proteins was assessed using BLAST, InterProScan and KEGG database searches.
Computational studies on the possible interactions between SM and identified proteins were carried out by a
battery of online servers and softwares, namely, CLUSTALW (KEGG), I-TASSER, VMD, PatchDock and FireDock. On
comparing 2DE patterns, nine proteins were found consistently overexpressed in SM resistant isolates and were
identified as Rv0350, Rv0440, Rv1240, Rv3075c, Rv2971, Rv3028c, Rv2145c, Rv2031c and Rv0569. In silico docking
analysis showed significant interactions of SM with essential (Rv0350, Rv0440 and Rv2971) and non essential
(Rv1240, Rv3075c and Rv2031c) genes.
Conclusions: The computational results suggest high protein binding affinity of SM and suggested many possible
interactions between identified proteins and the drug. Bioinformatic analysis proves attributive for analysis of
diversity of proteins identified by whole proteome analysis. In-depth study of the these proteins will give an insight
into probable sites of drug action other than established primary sites and hence may help in search of novel
chemotherapeutic agents at these new sites as inhibitors.
Background
Tuberculosis is one of the most challenging infectious
diseases. Globally, 9.2 million new cases and 1.7 million
deaths occur due to this disease [1]. Its impact on public
health is further aggravated by co-infection with human
immunodeficiency virus, emergence of multi-drug resis-
tant strains and reactivation of the dormant bacteria.
Attempt for primary prevention using Bacillus Calmette
Guerin (BCG) and other integral vaccines have generally
been disappointing though some subunit vaccines are
under trial [2]. The excessive emergence of drug resis-
tant tuberculosis has stimulated interest in the under-
standing of the underlying mechanisms of drug
resistance in Mycobacterium tuberculosis and significant
progress has been made in this field [3]. Streptomycin
(SM) is first line anti-tuberculosis drug and preferred
for treatment of relapses. It inhibits protein synthesis in
susceptible bacteria by interacting with steps of transla-
tion. Modification of the primary target of the drug by
mutations in the genes encoding either the 16 S rRNA
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of SM and is clinically significant in Mycobacterium spe-
cies [4,5]. However, nearly one third of resistant isolates
of M. tuberculosis do not have these mutations suggest-
ing the involvement of some other mechanism(s)
responsible for resistance [6-8]. Role of efflux pumps in
SM resistance have been demonstrated by inhibitor
assays [9]. Recently an acetyltransferase gene Rv0262c
[10] and mutation within gidB gene [11] have also been
reported to confer low level SM resistance in M. tuber-
culosis. Still there is a scope for unraveling more under-
lying mechanisms for SM resistance.
Two-dimension gel electrophoresis (2DE) along with
mass spectrometry is a powerful and direct tool to study
differential protein expression in cells. Identification and
characterization of mycobacterial proteins as drug tar-
gets, diagnostics and vaccine candidates have been pop-
ular research objectives, but comparative proteome
profiling of drug susceptible and resistant isolates
remain unexplored in relation to SM. Therefore, the
aim of the present study was to compare the protein
profiles of cell extracts from M. tuberculosis isolates sen-
sitive and resistant to SM.
Results
This study was focused on the proteins overexpressed
in SM resistant M. tuberculosis clinical isolates. Protein
profiles were compared by 2DE run in triplicates for
each isolate. 2DE patterns for SM susceptible and SM
resistant isolates are shown as Additional File 1 and
Additional File 2 respectively. Spots appearing consis-
tently overexpressed among resistant isolates were
further processed. We found nine protein spots to be
overexpressed in SM resistant isolates in comparison
to sensitive isolates (Figure 1). Magnified regions of
these overexpressed proteins are shown in Figure 2.
These protein spots were further identified as DnaK,
60 kDa chaperonin2, Malate dehydrogenase, Probable
oxidoreductase, Electron transfer flavoprotein subunit
alpha, Antigen 84, 14 kDa antigen and two hypotheti-
cal proteins by matrix-assisted laser desorption/ioniza-
tion time-of-flight (MALDI-TOF) mass spectrometry
(Table 1) and identity also confirmed by MS/MS
(Table 2). The level of over expression has been repre-
sented as densitometric ratio in Table 1. All the spots
except one exhibited at least two fold over expression.
However, Antigen 84 overexpressed maximally more
than four fold.
Results of computational analysis of all nine overex-
pressed proteins using different softwares and servers
are as follows.
BLAST Analysis
Blastp analysis was carried out for two hypothetical
proteins and two proteins with unknown functions.
Hypothetical protein (Rv3075c) was found highly
conserved (99 ± 0.05% identical) in few species of myco-
bacteria and in others it acts as citrate lyase subunit
beta-like protein (CitE) or HpcH/HpaI aldolase. Other
one hypothetical protein (Rv0569) was also found highly
conserved in mycobacteria and other microbes and sig-
nificant function could not be assigned except in few
microbes as signal-transduction protein (Frankia and
Nocardioides sps.) and DNA-binding protein (Strepto-
myces coelicolor &S. lividans). Probable oxidoreductase
(Rv2971) appeared highly conserved in some species of
Figure 1 Composite images of 2 D gels of proteins extracted from M. tuberculosis clinical isolates: (a) SM susceptible, (b) SM resistant.
Spots indicated by arrow were excised and analyzed by MS.
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reductase A (M. avium)o rm o r p h i n e6 - d e h y d r o g e n a s e
(M. smegmatis). Probable electron transfer flavoprotein
alpha-subunit (fixb) was also highly conserved in myco-
bacteria and other microbes.
Phylogenetic analysis
CLUSTALW analysis was performed for all overex-
pressed proteins. Rv0350, Rv0440 and Rv1240 were
highly conserved among all organisms and Rv0350 had
51% homology with human heat shock 70 kDa protein,
Figure 2 Magnified regions of 2 D gels showing the overexpressed proteins (a) sensitive isolate; (b) SM resistant isolate.
Table 1 Details of overexpressed proteins identified by MALDI-TOF mass spectrometry in SM resistant M. tuberculosis
clinical isolates
Spot
No.
†
Accession No. Proteins identified Mascot
score
Nominal
mass
(Da)
pI No. of
peptides
matched
Sequence
coverage
(%)
ORF
No.
Densitometric ratio of protein
expression between sensitive vs.
resistant isolates
1. P0A5B9
(DNAK_MYCTU)
Chaperone protein
dnaK
165 66790 4.85 22 38 Rv0350 1: 1.48
2. P0A520
(CH602_MYCTU)
60 kDa chaperonin 2 85 56692 4.85 12 27 Rv0440 1: 3.17
3. P0A5J6
(MDH_MYCTU)
Malate
dehydrogenase
103 34358 4.65 11 51 Rv1240 1: 2.45
4. P95083
(P95083_MYCTU)
Hypothetical protein 98 33194 4.73 9 28 Rv3075c 1: 3.69
5. P95124
(Y2971_MYCTU)
Probable
oxidoreductase
97 30516 4.70 11 47 Rv2971 1: 3.10
6. O53275
(ETFA_MYCTU)
Electron transfer
flavoprotein subunit
alpha (a-ETF)
118 31672 4.71 11 42 Rv3028c 1: 2.97
7. P0A5N2
(AG84_MYCTU)
Antigen 84 132 28260 4.80 9 44 Rv2145c 1: 4.27
8. P0A5B7
(ACR_MYCTU)
14 kDa Antigen (16
kDa Antigen,
HSP16.3)
117 16217 5.00 9 70 Rv2031c 1: 2.69
9. O53766
(Y0569_MYCTU)
Hypothetical protein 80 9517 5.70 5 54 Rv0569 1: 2.43
†Spot number of protein marked in Figure 1 & Figure 2.
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Page 3 of 11Table 2 MALDI-TOF/TOF (MS/MS) analysis of all nine overexpressd proteins in SM resistant M. tuberculosis
clinical isolates
Spot
No.
Peak Mass
(Da)
Protein Identified Nominal
mass
Mascot
Score
pI Sequence of peptide ORF
No.
1 1062.611 Chaperone protein dnaK 66790 33 4.85 RTTPSIVAFARN Rv0350
1226.711 Chaperone protein dnaK 66790 34 4.85 KDAGQIAGLNVLRI Rv0350
1567.931 Chaperone protein dnaK 66790 61 4.85 KLLGSFELTGIPPAPRG Rv0350
1645.962 Chaperone protein dnaK 66790 40 4.85 RIVNEPTAAALAYGLDKG Rv0350
2613.426 Chaperone protein dnaK 66790 60 4.85 RSETFTTADDNQPSVQIQVYQGERE Rv0350
2 940.555 60 kDa Chaperonin 2 56692 58 4.85 KDLLPLLEKV Rv0440
1503.710 60 kDa Chaperonin 2 56692 45 4.85 KGYISGYFVTDPERQ Rv0440
1658.900 60 kDa Chaperonin 2 56692 89 4.85 KQIAFNSGLEPGVVAEKV Rv0440
1790.868 60 kDa Chaperonin 2 56692 20 4.85 KDETTIVEGAGDTDAIAGRV Rv0440
2075.110 60 kDa Chaperonin 2 56692 65 4.85 KTDDVAGDGTTTATVLAQALVRE Rv0440
2203.240 60 kDa Chaperonin 2 56692 114 4.85 KKTDDVAGDGTTTATVLAQALVRE Rv0440
2317.275 60 kDa Chaperonin 2 56692 62 4.85 KVVVTKDETTIVEGAGDTDAIAGRV Rv0440
3 1693.989 Malate Dehydrogenase 34358 52 4.65 RLASGSLLGPDRPIELRL Rv1240
1722.957 Malate Dehydrogenase 34358 38 4.65 KVAVTGAAGQIGYSLLFRL Rv1240
1879.944 Malate Dehydrogenase 34358 56 4.65 KGGNWTIVSGLEIDEFSRG Rv1240
2423.360 Malate Dehydrogenase 34358 52 4.65 RVGVTGNPANTNALIAMTNAPDIPRE Rv1240
4 995.545 Hypothetical Protein Rv3075c 33194 30 4.73 RLAFGIGDFRR Rv3075c
1016.503 Hypothetical Protein Rv3075c 33194 26 4.73 KEFFAEFARD Rv3075c
1322.619 Hypothetical Protein Rv3075c 33194 63 4.73 RWFGDGNADWVRI Rv3075c
1491.919 Hypothetical Protein Rv3075c 33194 32 4.73 RLPNVPIVALVETARG Rv3075c
1583.780 Hypothetical Protein Rv3075c 33194 64 4.73 RDTGFGEDPATLAYARS Rv3075c
1648.036 Hypothetical Protein Rv3075c 33194 45 4.73 KRLPNVPIVALVETARG Rv3075c
5 897.627 Probable Oxidoreductase 30516 15 4.70 KTPAQVLLRW Rv2971
1105.658 Probable Oxidoreductase 30516 27 4.70 KLATPDQGFTRS Rv2971
1368.911 Probable Oxidoreductase 30516 72 4.70 RWNLQLGNAVVVRS Rv2971
1382.701 Probable Oxidoreductase 30516 12 4.70 RWNLQLGNAVVVRS Rv2971
6 1069.609 Electron transfer flavoprotein subunit
alpha
31672 43 4.71 KVAPQLTEAIKA Rv3028c
1341.748 Electron transfer flavoprotein subunit
alpha
31672 56 4.71 RIGSGLLVDVVDVRE Rv3028c
1577.902 Electron transfer flavoprotein subunit
alpha
31672 113 4.71 MAEVLVLVEHAEGALKK Rv3028c
1706.093 Electron transfer flavoprotein subunit
alpha
31672 65 4.71 MAEVLVLVEHAEGALKKV Rv3028c
1973.063 Electron transfer flavoprotein subunit
alpha
31672 69 4.71 RAAVDSGYYPGQFQVGQTGKT Rv3028c
2024.322 Electron transfer flavoprotein subunit
alpha
31672 67 4.71 KTVSPQLYIALGISGAIQHRA Rv3028c
2692.697 Electron transfer flavoprotein subunit
alpha
31672 14 4.71 KNGLVLVIDGQLWTITEFQHVKPGKG Rv3028c
7 1088.702 Antigen 84 28260 22 4.80 RLIEENSDLRQ Rv2145c
1171.748 Antigen 84 28260 32 4.80 RANAEQILGEARH Rv2145c
1807.228 Antigen 84 28260 38 4.80 RLKTYLESQLEELGQRG Rv2145c
1817.241 Antigen 84 28260 33 4.80 RVLSLAQDTADRLTNTAKA Rv2145c
8 885.507 14 kDa antigen 16217 21 5.00 MATTLPVQRH Rv2031c
1162.563 14 kDa antigen 16217 47 5.00 RSEFAYGSFVRT Rv2031c
1715.053 14 kDa antigen 16217 28 5.00 KGILTVSVAVSEGKPTEKH Rv2031c
1869.098 14 kDa antigen 16217 46 5.00 RAELPGVDPDKDVDIMVRD Rv2031c
9 929.516 Hypothetical protein Rv0569 9517 22 5.70 KVGDWLVIKG Rv0569
1109.493 Hypothetical protein Rv0569 9517 12 5.70 KGATIDQPDHRG Rv0569
1163.530 Hypothetical protein Rv0569 9517 4 5.70 RSSDGSPPYVVRW Rv0569
1269.646 Hypothetical protein Rv0569 9517 17 5.70 RFGAVQSAILHARG Rv0569
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60 kDa protein-1 and Rv1240 exhibited 48.93% homol-
ogy with human malate dehydrogenase. Rv3075c had
20.19% homology with CitE of human, 86.31% with
M. marinum & 85.66% with M. ulcerans, Rv2971
revealed 34% homology with human aldo-keto reductase
and Rv3028c had 39% homology with human electron
transfer flavoprotein. Rv2145c had 18.34% homology
with ankyrin repeat domain 24 protein of human.
Rv2031c had 29.86% homology with HSP20/alpha crys-
tallin family protein of M. avium and 20% homology
with 18 kDa antigen of M. leprae. However it showed
17% homology with human outer dense fiber of sperm
tails protein. The hypothetical protein (Rv0569) did not
show homology with any human protein.
InterProScan analysis
InterProScan analysis of Rv0350 showed nine signature
motifs [SPRINT: PR00301] (Figure 3a) and motifs 1, 5
and 6 were most conserved [INTERPRO: IPR018181].
One peptide binding domain [SUPERFAMILY:
SSF100920] and two actin like ATPas domains were also
present in it [SUPERFAMILY: SSF53067]. Rv0440 showed
five conserved motifs [SPRINT: PR00298], one conserved
site (from residues 403-414) for 60 kDa Chaperonin
[INTERPRO: IPR018370] (Figure 3b) and GroEL apical
domain like region from residues 182-374 [SUPERFAM-
ILY: SSF52029]. Rv1240 revealed one characteristic motif
which provides a signature for L-lactate/malate dehydro-
genase [PFAM: PF00056], one active site from residues
156-168 [PROSITE: PS00068] (Figure 3c) and NAD (P)-
binding Rossmann fold domains [SUPERFAMILY:
SSF51735]. Rv3075c showed characteristic HpcH-HpaI
motifs [PFAM: PF03328], phosphoenolpyruvate/pyruvate
domain from residues 22 to 239 [SUPERFAMILY:
SSF51621] and citrate lyase beta subunit domain from
residues 1-288 which provides a signature for lyase/aldo-
lase activity [UNIPROT: PIRSF015582]. Rv2971 showed
five Aldo/keto reductase subgroups 43-67, 99-117, 131-
148, 165-194 and 202-226 [SPRINT: PR00069] out of
which one is conserved site of aldo/keto reductase from
residues 131-148 [PROSITE: PS00062] (Figure 3e).
Rv3028c showed alpha/beta-subunit motif from residues
4-125 [PFAM: PF01012], one alpha subunit from residues
197-227 [PFAM: PF00766] and one conserved site found
from residues 257-283 in alpha subunit at C-terminal side
[PROSITE: PS00696] (Figure 4a). Rv2145c showed divIVA
motif from residues 3-61 [PFAM: PF05103] and DivIVA
domain from residues 3-39 [CMR: TIGR03544] (Figure
4b). Rv2031c confirmed its relation with Hsp20/alpha
crystallin family [PFAM: PF00011], heat shock hsp20 pro-
teins family profile [PROSITE: PS01031] and HSP20-like
chaperone [SUPERFAMILY: SSF49764]. Amino acid resi-
dues were almost common for showing its relation with
all three families. Signature for chaperone proteins and
HSP20 family motif is also present in the same region
from residues 22-142 [PANTHER: PTHR11527]. Rv0569
showed domain of unknown function DUF1918 from resi-
dues 1-58 [PFAM: PF08940] (Figure 4c). None of the nine
proteins had signal peptide or transmembrane domains
neither they had any site for post translational
modifications.
3D modeling and docking
All selected 3D models showed less than 2% discrepancy
from Ramachandran plot. These models were further
explored for in silico docking studies to identify the
binding of SM. Parameters used for selection of 3D
models and their docking with SM are represented in
Table 3. There were possible active cavities observed on
the surface of the 3D structures. Molecular docking of
SM with secondary structures of Rv0350, Rv0440,
Rv1240 & Rv3075c proteins showed successful binding
(Figure 3) into the central cavity of the protein and the
drug molecule fits well in the cavity. However, with
Rv0350 and Rv3075c, drug showed binding at the con-
served active site whereas in Rv1240, SM is interacting
with four residues of conserved active site and for
Rv0440 drug showed binding in the close vicinity of the
conserved site. In docked complex of Rv2971 and
Rv2031c, binding of drug was far from the conserved/
active site (Figure 3). Remaining three proteins Rv3028c,
Rv2145c & Rv0569 did not show significant binding of
the drug and their 3D models are shown in Figure 4.
Discussion
The 2DE profile of SM resistant M. tuberculosis clinical
isolates exhibited many proteins that were overex-
pressed. Protein spots 1 and 2 are chaperone protein 70
kDa DnaK (Rv0350) and 60 kDa Chaperonin-2/GroEL-2
(Rv0440) respectively. These essential genes prevent
misfolding and promote the refolding and proper assem-
bly of unfolded/misfolded polypeptides generated under
stress conditions. Rv0350 have characteristic peptide
binding domain and ATPase domain, which indicate its
role in active protein refolding and proper assembly.
The most conserved motifs are interacting with docked
SM which indicates that the drug may inhibit/modulate
the functioning of this protein and might influence SM
toxicity. In prokaryotes DnaK is known to negatively
regulate/auto-regulate expression of many HSP proteins
by promoting degradation of s
32 heat shock transcrip-
tional regulator [12] and s
32 regulates over expression
of other HSPs [13]. Thus blocking of DnaK activity not
only positively regulates its expression but may also
change HSP profile of the cell. Rv0350 has also been
found overexpressed in SM induced culture of SM
mono-resistant clinical isolate of M. tuberculosis [14].
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nin in M.tuberculosis g e n o m e .T h i sg e n ei ss i t u a t e d
away from classic GroEL-Cpn10 operon and suggests a
specialised regulation in M.tuberculosis.S Ms h o w e d
binding in the close vicinity of the conserved site on the
apical domain, which is a peptide binding domain [15]
and therefore it may be predicted that it could be a pos-
sible inhibitor/modulator. Duplicate copies of this gene
suggest its importance as an energy independent cha-
peronin in slow metabolism efficient genome of M.
tuberculosis [16]. Over expression of this gene could
be to compensate inhibited/modulated molecules or to
neutralise drug by binding. Further, spot 8 correspond-
ing to Rv2031c encodes 14 kDa antigen (HSP16.3/
HSPX) which is a member of the small heat-shock
protein family of chaperones. It has been shown to be
induced under oxygen-deficient conditions [17]. Its
role in maintenance of longt e r mv i a b i l i t yd u r i n g
latent, asymptomatic infections and in replication
during initial infection has also been proposed. Dock-
ing studies revealed that the SM binds to a demarcated
cavity comprising of 10 amino acids though the inter-
acting amino acids do not belong to any known activ-
ity region but these are highly conserved among
mycobacteria. These leads can be exploited for better
u n d e r s t a n d i n go ff u n c t i o no ft h e s ed o m a i n sb y
employing inhibition studies.
Spot 3 (Rv1240) encodes malate dehydrogenase, which
is involved in the conversion of malate to oxaloacetate.
Role of this protein in M. tuberculosis drug resistance
remains to be elucidated. SM interacts with the amino
acids of conserved active site of Rv1240, which suggests
that the drug can affect the activity of this enzyme. Spot
5 (Rv2971) belonging to oxidoreductase of aldo/keto
reductase family is probably involved in cellular metabo-
lism. Previous studies also found that this protein was
differentially expressed between BCG and H37Rv and
was regarded as a candidate antigen for development of
Figure 3 3D models of overexpressed proteins showing docking with SM. Residues constituting interacting site, active site and conserved
site are represented as space filled models with rest of the structure represented by cartoon structures. (a) Rv0350: Nine motifs are marked by
numerals, docking cavity and SM are indicated by arrows and motifs 4, 5 & 7 are interacting with SM. (b) Rv0440: Red coloured SM, green
coloured cavity and orange coloured conserved domain has been marked. Conserved domain is in the close vicinity of interacting site.
(c) Rv1240: SM (green) is interacting with active site residues (blue) and other residues in the close vicinity (yellow) in the cavity. (d) Rv3075c: SM
(yellow) interacting clearly with the central cavity residues (blue) of the globular protein. (e) Rv2971: SM (green) binding at the opposite side
(brown) from conserved site of aldo/keto reductase (light blue) in the protein. Central cavity is present in the middle of complete b-barrel.
(f) Rv2031c: SM (green) interacting with the outer part (yellow) of the protein in place of conserved HSP20-like chaperone domain.
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Page 6 of 11novel vaccine [18,19]. Furthermore, this protein has also
been reported to be differentially expressed between iso-
niazid (INH) susceptible and resistant strains [20]. Resi-
dues found interacting with SM were situated far from
conserved site and therefore it is suggested that this
protein might be playing a secondary role in imparting
resistance.
Spot 6 (Rv3028c) is an electron transfer flavoprotein
alpha subunit. Bioinformatic analysis indicated that
alpha subunit provides a signature for the electron
transfer flavoprotein family. The electron transfer flavo-
protein serves as a specific electron acceptor for other
dehydrogenases. It transfers the electrons to the main
r e s p i r a t o r yc h a i nv i aE T F - u b i q u i n o n eo x i d o r e d u c t a s e
(ETF dehydrogenase) [21] and participates in the oxida-
tion of fatty acids [22]. The 3D structure of Rv3028c
adopts a typical bi-lobed structure with four alpha
helices each packing against the hydrophobic beta sheet
comprising of 5 plates in alpha subunit motif and 7
plates in beta subunit interacting motif. No significant
in silico interactions with SM were found. Further stu-
dies regarding substrate specificity & interacting pro-
teins might reveal a relation with SM resistance. Spot 7
(Rv2145c) encodes antigen 84 and also corresponds to
wag31 which was originally identified as antigen of
pathogenic mycobacteria that is recognized by serum
from tuberculosis patients [23]. Studies indicate that this
gene is a homologue of the cell shape/cell division pro-
tein DivIVA and one of the substrates of PknA and
PknB [24]. Orthologs of Rv2145c have also been found
as immunogenic, cell division initiation protein or
secreted antigen Wag31 in some microbes. Rv3028c &
Rv2145c were also found overexpressed in INH resistant
M. tuberculosis isolates [20]. Its 3D structure showed
that the protein has a bi-lobbed ribbon structure
comprising mostly of alpha helices & the conserved site
of the protein had no evident interaction with SM.
Two protein spots 4 (Rv3075c) and 9 (Rv0569) which
encode hypothetical protein could not be assigned any
function. Phylogenetic analysis of these two proteins
revealed existence of their homologous sequences in
other mycobacterial species with known as well as
unknown functions and reflected dynamic and interest-
ing scenarios of evolutionary importance. Rv3075c,
besides showing homology with hypothetical protein,
also showed homology with CitE of some mycobacter-
ial species. While the bacterial citrate lyase is a
heterotrimeric complex with three subunits, the
M. tuberculosis genome does not contain a and g sub-
units of this complex, implying that M. tuberculosis
CitE act differently from other bacterial CitE proteins
[25]. These data hint that the biochemical function of
the M. tuberculosis and human CitE may differ from
other bacterial CitE proteins, and that M. tuberculosis
CitE may be critical for pathogenesis, encompassing
part of a novel pathway for fatty acid biosynthesis or
anaerobic energy metabolism [26].
SM docking with Rv3075c revealed that the drug
binds to the active site of the protein and interacts with
16 residues, out of which, one residue (162, Asp) has
been reported as a part of active site in E. coli [27,28].
Thus it is suggested that the SM is binding at the active
site of Rv3075c. It is assumed that the drug might inter-
fere with protein function. blastp analysis of the other
hypothetical protein (Rv0569) did not show any signifi-
cant identity (exhibited homology with hypothetical pro-
teins). Phylogenetic and blastp analysis exhibited that
Rv0569 might work as signal transduction protein or
DNA binding protein but no function has been assigned.
3D model of this protein showed semi-lunar beta barrel
Figure 4 3D models of proteins found non-interacting with SM represented by cartoon structures. (a) Rv3028c: Protein contains one
a-subunit motif and one b-subunit interacting motif and one conserved site in the a-subunit motif. (b) Rv2145c: Whole protein consists of only
a-helix and contains DivIVA domain indicating its role in cell division/cell shape. (c) Rv0569: Domain of unknown function (DUF1918) is present
in the b-barrel of protein.
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truding out instead of packing against hydrophobic beta
plates. Rv0569 showed no significant binding with SM.
It is quite likely that being a possible signaling protein it
might modulate the expression of other proteins.
Conclusions
To conclude, this study has employed proteomic
approach, which is a direct method, to identify proteins
from resistant M. tuberculosis isolates compared to sen-
sitive isolates. Nine protein spots were consistently over-
expressed in SM resistant isolates. We expect that these
proteins might be contributing in conferring resistant
phenotype to the isolates. Further these proteins were
subjected to advanced bioinformatics analysis to gener-
ate an understanding of the subtle relation of SM with
the overexpressed proteins. Homology searches and
InterProScan generated insights to the possible func-
tions and essential domains of the proteins. Rv0350,
Rv0440, Rv1240, Rv3075c, Rv2971 and Rv2031c showed
significant interaction in silico with SM thus their over
expression in the resistant isolates could be compensat-
ing the inhibited/modulated molecules. Other proteins
which are overexpressed but do not exhibit good bind-
ing with drug might be indirectly associated with SM.
The elucidated mechanisms and associations may be
further exploited to develop newer therapeutic agents
derived from SM.
Methods
Mycobacterial growth and drug susceptibility testing
Six SM resistant and three sensitive (to five first line
drugs) M. tuberculosis clinical isolates were obtained
from Mycobacterial Reposito r yC e n t r eo fo u rI n s t i t u t e .
Susceptibility testing was performed by conventional LJ
proportion method [29]. Bacteria were grown in Sau-
ton’s liquid medium at 37°C for four weeks (late log
phase).
Preparation of mycobacterial cell extract
Mycobacterial cell extract was prepared according to
modified protocol of Brodie et al., [30]. Cells were
washed three times with normal saline and then sus-
pended in sonication buffer (50 mM Tris-HCl contain-
ing 10 mM MgCl2, 0.1% sodium azide, 1 mM PMSF
and 1 mM EGTA; pH 7.4) at a concentration of 1 g wet
cell mass per 5 ml and then broken by intermittent
sonication for 15 min at 4°C using sonicator (Sonics &
Materials Inc, Newtown, CT, USA). The homogenate
was centrifuged at 12,000 g for 20 min at 4°C. Pellets
were discarded and supernatant was stored at -70°C
until used.
Table 3 3D modeling and docking parameters used for bioinformatic analysis
Identified
protein’s
ORF
number
TM-score RMSD
value (Å)
Global
energy
Attractive
Vander-
wall force
Repulsive
Vander-
wall force
ACE Interacting amino acid
residues
Remarks
Rv0350 0.75 ± 0.10 7.2 ± 4.2 -45.45, -24.49, 5.13 -9.21 11, 70, 71, 119, 121, 122, 126,
175, 177, 193-195 and 197
Interacting amino acids belong to
or are in close proximity of
signature motifs 1, 4 and 5
Rv0440 0.44 ± 0.08 5.4 ± 3.4 -42.74, -25.89, 5.64 -5.26 117, 172-175, 192, 206, 216,
212, 320, 322, 324, 326, 327,
329, 391, 395, 398, 399 and
402
Interacting residues are in the
close vicinity of the one
conserved site
Rv1240 0.94 ± 0.05 3.2 ± 2.2 -51.86, -22.83, 5.69 -15.08 156-168 Amino acid residues found
interacting with SM are from the
active site for function
Rv3075c 0.49 ± 0.15 10.5 ± 4.6 -44.95, -21.94, 5.20 -10.62 31, 57, 159-162, 165, 198, 200,
224, 226, 278, 281, 282, 285
and 286
amino acid residues found
interacting with SM are situated
at the central cavity of the
molecule
Rv2971 0.93 ± 0.06 2.9 ± 2.1 -41.57, -18.69, 6.30 -14.35 30, 31, 195-200, 237-340 and
243
amino acid residues found
interacting with SM are situated
far from the conserved site
(residue 131 to 148)
Rv3028c 0.99 ± 0.04 2.4 ± 1.8 -39.04, -21.43, 8.55 -10.03 poor docking -
Rv2145c 0.30 ± 0.09 15.4 ± 3.4 -35.93 -22.04 22.52 -13.70 poor docking -
Rv2031c 0.82 ± 0.09 3.2 ± 2.3 -41.10, -26.91, 19.30 -14.57 8, 10, 14, 18, 21, 22, 25, 28, 32
and 34
SM interacts with region
exclusively conserved in genus
Mycobacterium, no active site
found
Rv0569 0.83 ± 0.08 2.1 ± 1.7 -30.57, -17.34, 7.52 -12.89 poor docking -
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Cell extracts were treated with 1% SDS and then sub-
jected to trichloro acetic acid (TCA)-acetone precipita-
tion procedure [31]. 10% TCA was added to the cell
extract, the mixture was incubated at -20°C overnight
and then precipitated protein was collected by centrifu-
gation (18,000 g, 4°C, 15 min). It was again washed
twice with 100% ice cold acetone and allowed to air dry.
The protein pellet was suspended in appropriate volume
of two-dimensional rehydration buffer (BIO-RAD, Her-
cules, CA, USA). Protein concentration was estimated
using the Bradford assay [32].
Two-dimensional gel electrophoresis (2DE)
Isoelectric focusing (IEF) was carried out using the
method of ‘in gel rehydration’ [33] with slight modifi-
cations as described previously [34]. Immobilized pH
gradient (IPG) strips of pH 4-7 and length 17 cm
(BIO-RAD, Hercules, CA, USA) were rehydrated over-
night at 20°C with 500 μg protein which was mixed
with rehydration buffer. Strips were then focused on
an IEF unit PROTEAN IEF Cell (BIO-RAD, Hercules,
C A ,U S A )a t2 0 ° Cu s i n gt h ef o l l o w i n gf o u rs t e pp r o -
gram: a) 0-250 V for 2 h in linear mode; b) 250 V
constant for 2 h in rapid mode; c) 250-5000 V for 4 h
in linear mode; and d) 5000 V constant until 35 kVh
reached. The current limit was set at 50 μAp e rs t r i p .
After IEF, IPG strips were equilibrated for 15 min in
equilibration buffer I (6 M urea, 2% SDS, 0.375 M
Tris; pH 8.8, 20% glycerol) containing 130 mM
dithiothreitol (DTT) followed by equilibration buffer
II containing 135 mM iodoacetamide instead of DTT
for 15 min.
Proteins were separated in second dimension on 12%
SDS-PAGE [35] in a vertical electrophoretic dual gel
unit PROTEAN II XI (BIO-RAD, Hercules, CA, USA)
at constant voltage of 250 V for 5-6 h and gels were
stained with coomassie brilliant blue R250 to visualize
proteins. Images of gels were acquired by Chemidoc
(BIO-RAD, Segrate [Milan], Italy) using Quantity One
software (BIO-RAD, Hercules, CA, USA). 2 D gels
were analysed using PDQuest Advanced software (ver-
sion 8.0) (Bio-Rad, Hercules, CA, USA). Images were
analysed using stepwise spot detection and spot match-
ing followed by differential expression analysis.
PDQuest employs Student t-test and enumerates spots
with differential intensity of significant levels. Resultant
composite images for susceptible and resistant isolates
were manually checked for artifactual spots, merged
spots, and missed spots (Figure 1) and few spots with
more isolate specific variability were omitted in the
down stream processing. Equal amount of protein was
loaded in all gels and experiments were repeated at
least three times.
In-gel digestion with trypsin
Method of Shevchenko et al., [36] was followed with
slight modifications as described earlier [34]. Protein
spots of interest were excised from gels using spot
picker ‘Investigator ProPic’ (Genomic Solutions,
Huntingdon, UK) and collected in 96 well PCR plate.
Digestion of proteins and spotting of peptides on
MALDI-TOF target plate was carried out using protein
digester ‘Investigator ProPrep’ (Genomic Solutions,
H u n t i n g d o n ,U K ) .T h eg e lp l u g sw e r ed e s t a i n e da n d
dehydrated by washing three times (~10 min) with 25
mM NH4HCO3-50% acetonitrile (ACN) (1:1). Dried gel
plugs were treated with freshly prepared 10 mM DTT
in 50 mM NH4HCO3 for 45 min at 56°C. After incuba-
tion, the DTT was replaced quickly by the same volume
of freshly prepared 55 mM iodoacetamide in 50 mM
NH4HCO3 for 30 min and then dehydrated with 100%
ACN. The dried gel pieces were incubated for 12 h at
37°C with 25 mM NH4HCO3 containing 0.02 μg/μlo f
mass spectrometry grade trypsin (Promega, Madison,
WI, USA). The resulting peptides were extracted twice
from the gel pieces, using peptide extraction buffer
(1:1 mixture of 70% ACN and 0.1% trifluoroacetic
acid [TFA]).
Mass spectrometry
Mass spectrometry was carried out as described earlier
[34]. Digested samples were desalted and concentrated
on C-18 ZipTips (Millipore, Billerica, MA, USA) using
the manufacturer’s protocol. ZipTips were eluted on
MTP 384 target plate with 2 μlo fa-cyano-4-hydroxy-
cinnamic acid (HCCA) (Sigma-Aldrich, USA) saturated
solution dissolved in 50% ACN, 0.2% TFA. Mass spectra
of digested proteins were acquired using Autoflex II
TOF/TOF 50 (Bruker Daltonik GmbH, Leipzig,
Germany) in positive reflectron mode, in the detection
range of 500-3000 m/z. External calibration to a spec-
trum, acquired for a mixture of peptides with masses
ranging from 1046 to 2465 Da, was done prior to acqui-
sition. The proteolytic masses obtained were then pro-
cessed through Flex Analysis v.2.4 programme for peak
detection. Submission of peak lists to the UniProtKB/
Swiss-Prot database using the Mascot search engine
http://www.matrixscience.com to identify the proteins
from the annotated M. tuberculosis chromosome (strain
H37Rv, EMBL/GenBank/DDBJ entry AL123456) Release
20 (June 2010). The pI and molecular mass of proteins
were taken into account for identification of proteins
and we did not find any significant difference between
the experimental and predicted pI and molecular mass
of proteins. Peptide mass tolerance was set to 50 ppm
with carbamidomethyl-cystein set as fixed modification,
oxidation of methionine as variable modification and 1
missed cleavage site allowed. Few intense peaks from
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induced dissociation in MALDI-TOF/TOF. The MS⁄MS
spectra were calibrated internally to the precursor ion
mass and used for sequence specific search at mascot
database (Matrix science). In addition, peptide mass fin-
gerprint-based searches were carried out using only the
set of peptide masses, in the same database without any
constraints for isoelectric point (pI) and molecular mass.
The whole procedure was repeated several times to
ensure correct protein identification.
Bioinformatic analysis
Protein sequences of all nine overexpressed proteins were
retrieved from Tuberculist server http://genolist.pasteur.
fr/TubercuList/ hosted by Pasteur Institute, Paris for
whole annotated genome of H37Rv. BLAST [37] runs
were performed at NCBI server http://blast.ncbi.nlm.nih.
gov/ using the default threshold E-value of 10 and inclu-
sion threshold value of 0.005. Motif and domain searches
were made on EBI server http://www.ebi.ac.uk/Tools/
InterProScan/ employing InterProScan which uses 13
different homology search programs (blastprodom,
fprintscan, pfam, pir, panther, tigr, smart, superfamily,
g e n e 3d ,s c a n r e g e x p ,p r o f i l e s c a n ,s e g ,c o i l s ,t m ,s i g n a l p ,
GO). Orthologs of proteins from other species of myco-
bacteria and human were obtained from KEGG http://
www.genome.jp/kegg/ by single-directional best-hit
option (SBH) and same server was employed for multiple
sequence alignments (CLUSTALW) [38] we have used
the following combined set of 5 organisms: mtu
(M. tuberculosis), mbo (M.bovis), mav (M.avium), mle
(M. leprae) and hsa (Homo sapiens). Sequences of H37Rv
were submitted for 3-dimentional structure predictions
at I-TASSER server http://zhang.bioinformatics.ku.edu/
I-TASSER/. Structures were selected on the basis of
RMSD values and agreement with Ramachandran Plot
using VMD software (University of Illinois). Selected
structures were molecularly docked with SM (structure
obtained from http://www.drugbank.ca for in-silico inter-
actions studies by submitting the structures to Patch
Dock server [39] http://bioinfo3d.cs.tau.ac.il/PatchDock/
which is based on shape complementarity principles
and results were refined using FireDock server [40,41]
http://bioinfo3d.cs.tau.ac.il/FireDock/ which rearranges the
interface side chains and adjusts the relative orientation of
the molecules. Interacting amino acid side chains, drug
molecule orientation and docking feasibility was based on
Fire Dock scores and visualizations with VMD software.
Additional material
Additional file 1: 2DE patterns of three M. tuberculosis clinical
isolates. a, b & c are sensitive to all first line drugs. 500 μg of proteins
were first separated on 17 cm IPG strips of pH 4-7 by IEF and then by
12% SDS-PAGE in second dimension. Proteins were stained by coomassie
brilliant blue. Regions showing low expressed proteins are highlighted by
circles and squares.
Additional file 2: 2DE patterns of six M. tuberculosis clinical isolates.
a, b, c, d, e & f are resistant to SM. Regions showing overexpressed
proteins are highlighted by circles and squares.
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